Nevertheless, it was observed that i.p. administration of a 5-HT2C agonist, compound (+)-22a, improved OR LTM in a schizophrenia model (NR1-KD mice) (Cheng et al., 2016). This evidence concerns the gene HTR2C and schizophrenia.